Cision PR Newswire

Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer

Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept....

What Makes balabala Able to Speak for “Chinese Children”?

SHANGHAI, April 10, 2025 /PRNewswire/ -- How does a childrenswear brand spark nostalgia for childhood across generations in the whole nation? How does a...

Breaking Limits, Boosting Productivity: Dormer Pramet Unveils Multiple New Products at CIMT 2025

BEIJING, April 10, 2025 /PRNewswire/ -- A report from jgvogel. Dormer Pramet, a global leader in metal cutting tool innovation and a proud member...

FaceAnne Debuts in Malaysia: Bespoke Brightening Skincare with Cooling Feature

KUALA LUMPUR, Malaysia, April 10, 2025 /PRNewswire/ -- FaceAnne, a new skincare brand designed to meet the needs of the modern Malaysian consumer is...